Pre-Clinical Research
Non-clinical Safety Service
Our platform holds NMPA GLP certification and is equipped with 6,000 m² of laboratory space and advanced instrumentation. Backed by a professional team and a comprehensive quality control system, it fully meets all requirements for non-clinical drug safety evaluation.
Drug Research & Lab Testing
INTRODUCTION
BOJIMED has established a dedicated technology service platform for drug efficacy and safety research, which holds NMPA GLP certification. The platform encompasses approximately 6,000 m² of animal laboratories and support facilities.
Our platform is structured into eight specialized departments—including Pharmacology, PK & Bioanalysis, Toxicology, Quality Assurance, and Laboratory Animal Services—and two committees, such as the Institutional Animal Care and Use Committee. Over 50% of our staff hold senior or intermediate positions.
Equipped with nearly RMB 30 million worth of advanced instruments—including physiological telemetry systems, BIOPAC recorders, animal ultrasound, laser Doppler flowmeters, blood gas analyzers, flow cytometers, fully automated analyzers, and LC-MS/MS systems—we possess the full capability to conduct comprehensive pharmacology, pharmacokinetics, and safety evaluations for chemical drugs, biologics, traditional Chinese medicines, and select medical devices.
Our platform is structured into eight specialized departments—including Pharmacology, PK & Bioanalysis, Toxicology, Quality Assurance, and Laboratory Animal Services—and two committees, such as the Institutional Animal Care and Use Committee. Over 50% of our staff hold senior or intermediate positions.
Equipped with nearly RMB 30 million worth of advanced instruments—including physiological telemetry systems, BIOPAC recorders, animal ultrasound, laser Doppler flowmeters, blood gas analyzers, flow cytometers, fully automated analyzers, and LC-MS/MS systems—we possess the full capability to conduct comprehensive pharmacology, pharmacokinetics, and safety evaluations for chemical drugs, biologics, traditional Chinese medicines, and select medical devices.
SCALE & EXPERIENCE
-
500+Pharmacology Studies
-
200+DMPK Studies
-
500+Toxicological and Safety Evaluation Project
-
120+Teams
-
300+Facilities
DRUG RESEARCH & LAB TESTING
Developability Assessment
- New Compound Screening
- Formulation Research
- Early Phase PK Studies
- Compound Profiling through Early Efficacy and Safety Assessment
- Mechanism-Informed Formulation Exploration
- Specific Model Development
Clinical Laboratory Platform
- Blood Biochemistry Testing
- Complete Blood Count (CBC)
- Coagulation Function Testing
- Immunological Testing & Lymphocyte Subtyping
- Cell Cycle Analysis
- Urine Chemistry & Sediment Analysis
- Bone Marrow Cell Analysis
Toxicologic Pathology Platform
-
Routine Paraffin Sectioning
-
H&E Staining
-
Light Microscopic Examination
-
Immunohistochemical Staining
-
Various Special Stains & Targeted Organ Pathology
-
Eye Processing & Histopathological Evaluation
-
Cardiac Conduction System Histopathology